Recombinant Human Epidermal Growth Factor Gel Suppliers & Bulk Manufacturers
Available Forms: Gel
Available Strengths: 60MCG, 150 mcg
Reference Brands: Regen-D (India), Epifast (LATAM)
Category:
Medical Aid
Gel contains Recombinant Human Epidermal Growth Factor. It is used to treat first and second-degree burns. It is used to heal the scars of the skin grafts. Burns may be caused by accidental contact with fire, chemicals, electricity, or excessive sun exposure.
RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL is available in Gel
and strengths such as 60MCG, 150 mcg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
First-degree burn involves the superficial layer of the skin resulting in redness and pain. Second-degree burn affects 1st and 2nd layer of skin (epidermis and dermis), which may result in redness, blisters, severe pain, or scarring.
Recombinant Human Epidermal Growth Factor (rhEGF) Gel is a bioengineered form of the naturally occurring human epidermal growth factor, a polypeptide that plays an essential role in the regulation of cell growth, proliferation, and tissue repair. Produced using recombinant DNA technology, rhEGF is designed to support epithelial regeneration and enhance the body’s natural wound-healing processes.
When applied topically, rhEGF stimulates epithelial cell proliferation, differentiation, and migration, which helps accelerate the regeneration of damaged skin and tissues. This mechanism promotes faster wound closure and improves overall healing outcomes in various types of skin injuries. Recombinant Human Epidermal Growth Factor Gel is widely used in the management of chronic wounds such as diabetic foot ulcers, burns, surgical wounds, and other skin lesions that require enhanced tissue repair.
In addition to its regenerative effects, rhEGF may also provide cytoprotective benefits by helping to reduce epithelial damage associated with chemotherapy or radiotherapy. By supporting healthy cell growth and tissue recovery, Recombinant Human Epidermal Growth Factor Gel serves as an important therapeutic option in advanced wound care and dermatological treatment.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing